Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-11

Clinical Trial Update: Ofatumumab and Fresh Frozen Plasma in Patients With Chronic Lymphocytic Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial update of Ofatumumab plus Fresh Frozen Plasma in patients with chronic lymphocytic leukemia. Results posted; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ofatumumab (ofatumumab)

Snippet

Sponsor: Joseph Tuscano | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2021-05-11